Review
Copyright ©The Author(s) 2015.
World J Hepatol. Jun 8, 2015; 7(10): 1377-1389
Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1377
Figure 2
Figure 2 Hepatitis C virus NS5B acts as RNA-dependent RNA polymerase and plays an important role in the synthesis of new RNA genomes. As the central component of the hepatitis C virus replication complex, NS5B has emerged as a major target for antiviral treatment. New direct acting antivirals, specifically designed to inhibit the NS5B are now becoming available (e.g., sofosbuvir).